NMTC RSI Chart
Last 7 days
-0.9%
Last 30 days
-5.1%
Last 90 days
7.8%
Trailing 12 Months
-9.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 2.3M | 0 | 0 | 0 |
2023 | 1.3M | 1.9M | 2.4M | 0 |
2022 | 28.8K | 100.0K | 171.2K | 733.0K |
2021 | 1.0M | 567.2K | 114.0K | 48.9K |
2020 | 0 | 0 | 1.9M | 1.5M |
2014 | 1.6M | 0 | 0 | 0 |
2013 | 331.1K | 650.2K | 969.3K | 1.3M |
2012 | 0 | 0 | 0 | 12.0K |
2011 | 0 | 0 | 0 | 5.4K |
2010 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 30, 2024 | mertens steve | sold (taxes) | -284 | 1.13 | -252 | chief technology officer |
Apr 30, 2024 | christianson mark | sold (taxes) | -101 | 1.13 | -90.00 | business development director |
Apr 30, 2024 | rosa david a | sold (taxes) | -2,530 | 1.13 | -2,239 | ceo and president |
Apr 21, 2024 | mertens steve | sold (taxes) | -8,337 | 1.15 | -7,250 | chief technology officer |
Apr 21, 2024 | christianson mark | sold (taxes) | -2,334 | 1.15 | -2,030 | business development director |
Apr 21, 2024 | rosa david a | sold (taxes) | -22,623 | 1.15 | -19,673 | ceo and president |
Mar 31, 2024 | mertens steve | sold (taxes) | -302 | 1.2 | -252 | chief technology officer |
Mar 31, 2024 | christianson mark | sold (taxes) | -108 | 1.2 | -90.00 | business development director |
Mar 31, 2024 | rosa david a | sold (taxes) | -2,686 | 1.2 | -2,239 | ceo and president |
Feb 29, 2024 | rosa david a | sold (taxes) | -2,709 | 1.21 | -2,239 | ceo and president |
Which funds bought or sold NMTC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | AWM Investment Company, Inc. | unchanged | - | -550,999 | 1,740,000 | 0.23% |
May 15, 2024 | STATE STREET CORP | unchanged | - | -19,607 | 61,919 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | sold off | -100 | -48.00 | - | -% |
May 15, 2024 | Nemes Rush Group LLC | unchanged | - | -165 | 520 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 36.31 | 286 | 8,402 | -% |
May 15, 2024 | Nantahala Capital Management, LLC | reduced | -50.63 | -2,397,840 | 1,438,690 | 0.08% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | new | - | 13,572 | 13,572 | -% |
May 14, 2024 | NORTHERN TRUST CORP | unchanged | - | -11,507 | 36,337 | -% |
May 13, 2024 | UBS Group AG | reduced | -94.27 | -2,849 | 130 | -% |
May 13, 2024 | Mayo Clinic | unchanged | - | -69,066 | 218,105 | 3.55% |
Unveiling NeuroOne Medical Technologies Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to NeuroOne Medical Technologies Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
NeuroOne Medical Technologies Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2014Q1 | 2013Q4 | 2013Q3 | 2013Q2 | 2013Q1 | 2012Q4 | 2011Q4 |
Revenue | 177.0% | 1,377,294 | 497,253 | - | 466,176 | 1,455,188 | 970,125 | 485,063 | - | 6,374 | 4,974 | 17,451 | 20,113 | 71,474 | - | - | - | - | - | - | - | 297 |
Cost Of Revenue | 80.0% | 986,875 | 548,125 | 386,240 | 434,673 | 126,886 | 83,850 | 38,462 | 72,807 | 46,844 | 65,466 | 61,935 | 39,363 | 109,131 | - | - | - | - | - | - | - | - |
Gross Profit | 101.6% | 390,419 | 193,655 | 243,666 | 31,503 | -12,307 | -15,062 | -6,413 | -36,223 | -13,096 | -17,130 | -21,839 | -21,123 | -37,657 | - | 165 | 140 | 252 | 451 | 406 | 360 | - |
Operating Expenses | -2.4% | 3,276,517 | 3,358,399 | 3,753,901 | 3,527,422 | 3,227,233 | 3,327,632 | 2,755,021 | 3,023,587 | 2,802,603 | 2,631,967 | 3,030,608 | 2,394,681 | 2,128,018 | 2,043,991 | - | - | - | - | - | - | - |
S&GA Expenses | 26.8% | 2,002,949 | 1,579,035 | 1,862,389 | 1,821,108 | 1,663,737 | 1,889,398 | 1,529,670 | 1,818,207 | 1,742,141 | 1,623,680 | 2,129,474 | 1,313,252 | 1,193,860 | 1,259,275 | - | - | - | - | - | - | - |
R&D Expenses | -28.4% | 1,273,568 | 1,779,364 | 1,891,512 | 1,706,314 | 1,563,496 | 1,438,234 | 1,225,351 | 1,205,380 | 1,060,462 | 1,008,287 | 901,134 | 1,081,429 | 934,158 | 784,716 | - | - | - | - | - | - | - |
EBITDA Margin | -11.4% | -5.37 | -4.82 | -5.35 | -7.14 | -11.99 | -57.71 | -114 | -385 | -204 | 33.63 | 6.60 | -5.05 | -2.79 | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | 6,106 | - | - | -3,053 | -77,811 | - | - | - | - | - | - | - |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 8.9% | -2,855,090 | -3,135,121 | -3,468,773 | -3,522,828 | -1,732,769 | -1,374,344 | -2,759,727 | -3,058,067 | -2,807,475 | - | -2,951,609 | -2,393,916 | -1,959,480 | 11,055,921 | - | - | - | - | - | - | - |
EBT Margin | -11.6% | -5.47 | -4.90 | -5.44 | -7.25 | -12.18 | -58.42 | -115 | -389 | -206 | 32.90 | 6.61 | -0.38 | 0.45 | - | - | - | - | - | - | - | - |
Net Income | 8.9% | -2,855,090 | -3,135,121 | -3,468,773 | -3,522,828 | -1,732,769 | -1,374,344 | -2,759,727 | -3,058,067 | -2,807,475 | -2,643,163 | -2,951,609 | -2,393,916 | -1,959,480 | -566,392 | - | - | - | - | - | - | - |
Net Income Margin | -11.6% | -5.47 | -4.90 | -5.44 | -7.25 | -12.18 | -58.42 | -112 | -397 | -220 | -87.26 | -13.88 | -11.77 | -7.44 | - | - | - | - | - | - | - | - |
Free Cashflow | 25.5% | -2,206,523 | -2,960,446 | -3,079,550 | -3,727,230 | -3,503,765 | 951,635 | -2,690,858 | -3,314,910 | -2,740,627 | -2,064,415 | -2,319,329 | -2,436,229 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -7.3% | 5,395 | 5,822 | 8,097 | 5,758 | 7,205 | 9,660 | 12,823 | 11,571 | 14,089 | 17,183 | 7,938 | 9,809 | 11,917 | 7,913 | 4,760 | 4,462 | 1,389 | 2,659 | 533 | 1,536 | 2,575 |
Current Assets | -7.5% | 4,710 | 5,093 | 7,313 | 4,879 | 6,357 | 8,967 | 12,176 | 10,929 | 13,443 | 16,576 | 7,292 | 9,271 | 11,355 | 7,340 | 4,155 | 3,904 | 829 | 2,092 | 302 | 1,299 | 2,385 |
Cash Equivalents | -9.2% | 2,435 | 2,681 | 5,322 | 3,083 | 3,602 | 4,667 | 8,160 | 10,178 | 12,869 | 16,184 | 6,901 | 8,991 | 11,274 | 7,129 | 4,036 | 3,824 | 747 | 2,044 | 261 | 1,247 | 2,305 |
Inventory | -18.5% | 1,312 | 1,609 | 1,727 | 1,517 | 1,174 | 904 | 705 | 454 | 222 | 229 | 98.00 | 52.00 | - | 14.00 | - | - | - | - | - | - | - |
Net PPE | -1.8% | 496 | 505 | 526 | 587 | 523 | 335 | 354 | 315 | 287 | 217 | 223 | 156 | 161 | 153 | 166 | 101 | 85.00 | 68.00 | 52.00 | 53.00 | - |
Liabilities | 9.7% | 1,540 | 1,404 | 1,848 | 1,837 | 1,672 | 1,488 | 3,218 | 952 | 966 | 1,236 | 1,385 | 954 | 1,057 | 6,505 | 2,694 | 8,389 | 6,574 | 7,271 | 1,770 | 1,809 | 2,130 |
Current Liabilities | 11.4% | 1,540 | 1,383 | 1,793 | 1,748 | 1,550 | 1,335 | 3,099 | 815 | 810 | 1,062 | 1,182 | 747 | 750 | 6,183 | 2,356 | 8,037 | 6,290 | 6,973 | 1,770 | 1,809 | 2,130 |
Short Term Borrowings | - | 122 | - | 129 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 229 |
Shareholder's Equity | -12.8% | 3,854 | 4,418 | 6,249 | 3,921 | 5,533 | 8,172 | 9,604 | 10,618 | 13,122 | 15,948 | 6,554 | 8,855 | 10,860 | 1,408 | 2,066 | - | - | - | - | - | 445 |
Retained Earnings | -4.3% | -68,900 | -66,031 | -62,686 | -59,551 | -56,100 | -52,559 | -50,826 | -49,452 | -46,692 | -43,634 | -40,827 | -38,184 | -35,232 | -32,838 | -30,879 | -30,312 | -23,221 | -21,875 | -17,238 | -15,885 | -14,022 |
Additional Paid-In Capital | 3.3% | 72,714 | 70,425 | 68,912 | 63,455 | 61,598 | 60,715 | 60,415 | 60,055 | 59,775 | 59,542 | 47,369 | 47,003 | 46,057 | 34,224 | 32,923 | 26,368 | 18,022 | 17,250 | 15,988 | 15,599 | 14,454 |
Shares Outstanding | 6.0% | 26,322 | 24,831 | 23,929 | 17,862 | 16,888 | 16,231 | 16,217 | 15,928 | 15,795 | 15,408 | 12,010 | 10,269 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | 24,808 | - | - | - | 17,000 | - | - | - | 82,500 | - | - | - | 17,100 | - | - | - | 37,700 |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 42.9% | -2,175 | -3,809 | -2,902 | -2,940 | -3,551 | -3,492 | 1,018 | -2,636 | -3,221 | -2,679 | -2,029 | -2,289 | -2,379 | -1,904 | 273 | -1,222 | -1,250 | -1,224 | -1,142 | -1,676 | -1,876 |
Share Based Compensation | 15.6% | 357 | 309 | 271 | 296 | 238 | 300 | 256 | 256 | - | - | - | - | - | - | - | - | - | - | -97.08 | 232 | 70.00 |
Cashflow From Investing | 15.5% | -31.36 | -37.13 | -50.12 | 861 | 1,824 | 15.00 | -3,035 | -54.23 | -93.32 | -61.49 | -35.11 | -29.91 | - | - | -56.36 | -25.84 | -29.95 | -10.27 | -4.40 | -53.95 | - |
Cashflow From Financing | 62.7% | 1,960 | 1,205 | 5,192 | 1,561 | 662 | -15.71 | - | - | -322* | 12,024 | -24.98 | 36.00 | 6,527 | 4,997 | -3.87 | 4,325 | -16.87 | 3,019 | 161 | 672 | 3,896 |
Buy Backs | -16.7% | 11.00 | 14.00 | - | - | 99.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||||
Product revenue | $ 1,377,294 | $ 466,176 | $ 2,354,943 | $ 580,755 |
Cost of product revenue | 986,875 | 434,673 | 1,698,210 | 561,559 |
Product gross profit | 390,419 | 31,503 | 656,733 | 19,196 |
Collaborations revenue | 1,455,188 | |||
Operating expenses: | ||||
Selling, general and administrative | 2,002,949 | 1,821,108 | 4,176,421 | 3,484,845 |
Research and development | 1,273,568 | 1,706,314 | 2,756,885 | 3,269,810 |
Total operating expenses | 3,276,517 | 3,527,422 | 6,933,306 | 6,754,655 |
Loss from operations | (2,886,098) | (3,495,919) | (6,276,573) | (5,280,271) |
Other income (expense), net | 31,008 | (26,909) | 76,583 | 24,674 |
Loss before income taxes | (2,855,090) | (3,522,828) | (6,199,990) | (5,255,597) |
Provision for income taxes | ||||
Net loss | $ (2,855,090) | $ (3,522,828) | $ (6,199,990) | $ (5,255,597) |
Net loss per share: | ||||
Basic (in Dollars per share) | $ (0.11) | $ (0.21) | $ (0.25) | $ (0.32) |
Number of shares used in per share calculations: | ||||
Basic (in Shares) | 25,910,478 | 16,414,795 | 24,947,813 | 16,321,891 |
Condensed Balance Sheets - USD ($) | Mar. 31, 2024 | Sep. 30, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 2,434,655 | $ 5,322,493 |
Accounts receivable | 555,639 | |
Inventory | 1,311,673 | 1,726,686 |
Prepaid expenses | 407,777 | 263,746 |
Total current assets | 4,709,744 | 7,312,925 |
Intangible assets, net | 78,419 | 89,577 |
Right-of-use assets | 110,724 | 169,059 |
Property and equipment, net | 496,015 | 525,753 |
Total assets | 5,394,902 | 8,097,314 |
Current liabilities: | ||
Accounts payable | 780,839 | 685,104 |
Accrued expenses and other liabilities | 759,620 | 1,107,522 |
Total current liabilities | 1,540,459 | 1,792,626 |
Operating lease liability, long term | 55,284 | |
Total liabilities | 1,540,459 | 1,847,910 |
Commitments and contingencies (Note 4) | ||
Stockholders’ equity: | ||
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued or outstanding. | ||
Common stock, $0.001 par value; 100,000,000 shares authorized; 26,321,750 and 23,928,945 shares issued and outstanding as of March 31, 2024 and September 30, 2023, respectively. | 26,322 | 23,929 |
Additional paid–in capital | 72,714,414 | 68,911,778 |
Accumulated deficit | (68,886,293) | (62,686,303) |
Total stockholders’ equity | 3,854,443 | 6,249,404 |
Total liabilities and stockholders’ equity | $ 5,394,902 | $ 8,097,314 |